We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Nooka - The Improved Efficacy of Bortezomib Containing Induction Regimens (BCIR) Versus Non-Bortezomib Containing Induction Regimens (NBCIR) in Transplant-Eligible Patients with Multiple Myeloma (MM): Meta-Analysis of Phase III Randomized Controlled Trials (RCTs)
Ajay Nooka, MD, MPH, FACP
Winship Cancer Institute of Emory University
Atlanta, Georgia, USA
12.07.11


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles